A 0 1 0 1 O
serum 2 7 2 7 B-clinical_variable
creatinine 8 18 8 18 I-clinical_variable
based 19 24 19 24 O
on 25 27 25 27 O
age 28 31 28 31 B-age

Age 0 3 32 35 B-age
( 4 5 36 37 O
Years 5 10 37 42 O
) 10 11 42 43 O
Maximum 12 19 44 51 B-clinical_variable
Serum 20 25 52 57 I-clinical_variable
Creatinine 26 36 58 68 I-clinical_variable
( 37 38 69 70 O
mg 38 40 70 72 O
/ 40 41 72 73 O
dL 41 43 73 75 O
) 43 44 75 76 O

All 0 3 77 80 O
patients 4 12 81 89 O
must 13 17 90 94 O
have 18 22 95 99 O
one 23 26 100 103 O
of 27 29 104 106 O
the 30 33 107 110 O
following 34 43 111 120 O
vascular 44 52 121 129 B-chronic_disease
anomalies 53 62 130 139 I-chronic_disease
as 63 65 140 142 O
determined 66 76 143 153 O
by 77 79 154 156 O
clinical 80 88 157 165 O
, 88 89 165 166 O
radiologic 90 100 167 177 O
and 101 104 178 181 O
histologic 105 115 182 192 O
criteria 116 124 193 201 O

Concurrent 0 10 202 212 O
severe 11 17 213 219 O
and/or 18 24 220 226 O
uncontrolled 25 37 227 239 O
medical 38 45 240 247 O
disease 46 53 248 255 O
that 54 58 256 260 O
could 59 64 261 266 O
compromise 65 75 267 277 O
participation 76 89 278 291 O
in 90 92 292 294 O
the 93 96 295 298 O
study 97 102 299 304 O
( 103 104 305 306 O
e.g. 104 108 306 310 O
uncontrolled 109 121 311 323 O
diabetes 122 130 324 332 B-chronic_disease
, 130 131 332 333 O
uncontrolled 132 144 334 346 O
hypertension 145 157 347 359 B-chronic_disease
, 157 158 359 360 O
severe 159 165 361 367 O
infection 166 175 368 377 O
, 175 176 377 378 O
severe 177 183 379 385 B-chronic_disease
malnutrition 184 196 386 398 I-chronic_disease
, 196 197 398 399 O
chronic 198 205 400 407 B-chronic_disease
liver 206 211 408 413 I-chronic_disease
or 212 214 414 416 O
renal 215 220 417 422 B-chronic_disease
disease 221 228 423 430 I-chronic_disease
, 228 229 430 431 O
active 230 236 432 438 O
upper 237 242 439 444 B-chronic_disease
GI 243 245 445 447 I-chronic_disease
tract 246 251 448 453 I-chronic_disease
ulceration 252 262 454 464 I-chronic_disease
) 262 263 464 465 O

Fasting 0 7 466 473 B-clinical_variable
LDL 8 11 474 477 I-clinical_variable
cholesterol 12 23 478 489 I-clinical_variable
of 24 26 490 492 O
< 27 28 493 494 O
160 28 31 494 497 B-upper_bound
mg 32 34 498 500 I-upper_bound
/ 34 35 500 501 I-upper_bound
dL 35 37 501 503 I-upper_bound

Fasting 0 7 504 511 O
triglyceride 8 20 512 524 B-clinical_variable
< 21 22 525 526 O
400 22 25 526 529 B-upper_bound
mg 26 28 530 532 I-upper_bound
/ 28 29 532 533 I-upper_bound
dl 29 31 533 535 I-upper_bound

Females 0 7 536 543 B-gender
who 8 11 544 547 O
are 12 15 548 551 B-pregnancy
pregnant 16 24 552 560 I-pregnancy

Hemoglobin 0 10 561 571 B-clinical_variable
> 11 12 572 573 O
/= 12 14 573 575 O
8.0 15 18 576 579 B-lower_bound
g 19 20 580 581 I-lower_bound
/ 20 21 581 582 I-lower_bound
dL 21 23 582 584 I-lower_bound

Impairment 0 10 585 595 B-chronic_disease
of 11 13 596 598 I-chronic_disease
gastrointestinal 14 30 599 615 I-chronic_disease
function 31 39 616 624 I-chronic_disease
or 40 42 625 627 O
gastrointestinal 43 59 628 644 B-chronic_disease
disease 60 67 645 652 I-chronic_disease
that 68 72 653 657 O
may 73 76 658 661 O
significantly 77 90 662 675 O
alter 91 96 676 681 O
the 97 100 682 685 O
absorption 101 111 686 696 O
of 112 114 697 699 O
sirolimus 115 124 700 709 B-treatment
( 125 126 710 711 O
e.g. 126 130 711 715 O
ulcerative 131 141 716 726 B-chronic_disease
disease 142 149 727 734 I-chronic_disease
, 149 150 734 735 O
uncontrolled 151 163 736 748 O
nausea 164 170 749 755 O
, 170 171 755 756 O
vomiting 172 180 757 765 O
, 180 181 765 766 O
diarrhea 182 190 767 775 O
, 190 191 775 776 O
malabsorption 192 205 777 790 B-chronic_disease
syndrome 206 214 791 799 I-chronic_disease
or 215 217 800 802 O
small 218 223 803 808 B-treatment
bowel 224 229 809 814 I-treatment
resection 230 239 815 824 I-treatment
) 239 240 824 825 O

Kaposiform 0 10 826 836 B-cancer
Hemangioendotheliomas 11 32 837 858 I-cancer

Kasabach 0 8 859 867 B-chronic_disease
Merritt 9 16 868 875 I-chronic_disease
Syndrome 17 25 876 884 I-chronic_disease
defined 26 33 885 892 O
at 34 36 893 895 O
a 37 38 896 897 O
platelet 39 47 898 906 B-clinical_variable
counts 48 54 907 913 I-clinical_variable
less 55 59 914 918 O
than 60 64 919 923 O
50,000 65 71 924 930 B-upper_bound
K/µl 72 76 931 935 I-upper_bound
and/or 77 83 936 942 O
fibrinogen 84 94 943 953 B-clinical_variable
level 95 100 954 959 I-clinical_variable
< 101 102 960 961 O
100 103 106 962 965 B-upper_bound
mg 107 109 966 968 I-upper_bound
/ 109 110 968 969 I-upper_bound
dl 110 112 969 971 I-upper_bound
at 113 115 972 974 O
the 116 119 975 978 O
time 120 124 979 983 O
of 125 127 984 986 O
diagnosis 128 137 987 996 O

Known 0 5 997 1002 O
history 6 13 1003 1010 O
of 14 16 1011 1013 O
HIV 17 20 1014 1017 B-chronic_disease
seropositivity 21 35 1018 1032 O
or 36 38 1033 1035 O
known 39 44 1036 1041 O
immunodeficiency 45 61 1042 1058 B-chronic_disease

Patients 0 8 1059 1067 O
must 9 13 1068 1072 O
be 14 16 1073 1075 O
0 17 18 1076 1077 B-lower_bound
- 19 20 1078 1079 O
31 21 23 1080 1082 B-upper_bound
years 24 29 1083 1088 I-upper_bound
of 30 32 1089 1091 O
age 33 36 1092 1095 B-age
at 37 39 1096 1098 O
the 40 43 1099 1102 O
time 44 48 1103 1107 O
of 49 51 1108 1110 O
study 52 57 1111 1116 O
entry 58 63 1117 1122 O

Patients 0 8 1123 1131 O
who 9 12 1132 1135 O
currently 13 22 1136 1145 O
have 23 27 1146 1150 O
an 28 30 1151 1153 O
uncontrolled 31 43 1154 1166 O
infection 44 53 1167 1176 B-chronic_disease
, 53 54 1176 1177 O
defined 55 62 1178 1185 O
as 63 65 1186 1188 O
receiving 66 75 1189 1198 O
intravenous 76 87 1199 1210 B-treatment
antibiotics 88 99 1211 1222 I-treatment

Patients 0 8 1223 1231 O
who 9 12 1232 1235 O
discontinue 13 24 1236 1247 O
use 25 28 1248 1251 O
of 29 31 1252 1254 O
prohibited 32 42 1255 1265 B-treatment
medications 43 54 1266 1277 I-treatment
with 55 59 1278 1282 O
a 60 61 1283 1284 O
one 62 65 1285 1288 B-upper_bound
week 66 70 1289 1293 I-upper_bound
washout 71 78 1294 1301 O
prior 79 84 1302 1307 O
to 85 87 1308 1310 O
start 88 93 1311 1316 O
of 94 96 1317 1319 O
study 97 102 1320 1325 B-treatment
treatment 103 112 1326 1335 I-treatment

Patients 0 8 1336 1344 O
who 9 12 1345 1348 O
have 13 17 1349 1353 O
received 18 26 1354 1362 O
prior 27 32 1363 1368 B-treatment
treatment 33 42 1369 1378 I-treatment
with 43 47 1379 1383 I-treatment
an 48 50 1384 1386 I-treatment
mTOR 51 55 1387 1391 I-treatment
inhibitor 56 65 1392 1401 I-treatment

Patients 0 8 1402 1410 O
who 9 12 1411 1414 O
require 13 20 1415 1422 O
medications 21 32 1423 1434 B-treatment
that 33 37 1435 1439 O
are 38 41 1440 1443 O
strong 42 48 1444 1450 O
inhibitors 49 59 1451 1461 O
/ 59 60 1461 1462 O
inducers 60 68 1462 1470 O
CYP3A4 69 75 1471 1477 B-treatment
enzyme 76 82 1478 1484 I-treatment
activity 83 91 1485 1493 O
, 91 92 1493 1494 O
including 93 102 1495 1504 O
anticonvulsants 103 118 1505 1520 B-treatment
, 118 119 1520 1521 O
( 120 121 1522 1523 O
Appendix 121 129 1523 1531 O
II 130 132 1532 1534 O
) 132 133 1534 1535 O
to 134 136 1536 1538 O
control 137 144 1539 1546 O
concurrent 145 155 1547 1557 O
medical 156 163 1558 1565 O
conditions 164 174 1566 1576 O

Peripheral 0 10 1577 1587 O
absolute 11 19 1588 1596 B-clinical_variable
neutrophil 20 30 1597 1607 I-clinical_variable
count 31 36 1608 1613 I-clinical_variable
( 37 38 1614 1615 I-clinical_variable
ANC 38 41 1615 1618 I-clinical_variable
) 41 42 1618 1619 I-clinical_variable
> 43 44 1620 1621 O
/= 44 46 1621 1623 O
1000 47 51 1624 1628 B-lower_bound
/ 51 52 1628 1629 I-lower_bound
uL 52 54 1629 1631 I-lower_bound

Prior 0 5 1632 1637 B-treatment
vincristine 6 17 1638 1649 I-treatment
therapy 18 25 1650 1657 I-treatment

Radiation 0 9 1658 1667 B-treatment
: 9 10 1667 1668 O
> 11 12 1669 1670 O
6 13 14 1671 1672 B-lower_bound
months 15 21 1673 1679 I-lower_bound
from 22 26 1680 1684 O
involved 27 35 1685 1693 O
field 36 41 1694 1699 O
radiation 42 51 1700 1709 B-treatment

SGPT 0 4 1710 1714 B-clinical_variable
( 5 6 1715 1716 I-clinical_variable
ALT 6 9 1716 1719 I-clinical_variable
) 9 10 1719 1720 I-clinical_variable
≤ 11 12 1721 1722 O
5 13 14 1723 1724 B-upper_bound
x 15 16 1725 1726 I-upper_bound
ULN 17 20 1727 1730 I-upper_bound
for 21 24 1731 1734 O
age 25 28 1735 1738 B-age

Serum 0 5 1739 1744 B-clinical_variable
albumin 6 13 1745 1752 I-clinical_variable
> 14 15 1753 1754 O
/= 15 17 1754 1756 O
2 18 19 1757 1758 B-lower_bound
g 20 21 1759 1760 I-lower_bound
/ 21 22 1760 1761 I-lower_bound
dL 22 24 1761 1763 I-lower_bound

Surgery 0 7 1764 1771 B-treatment
: 7 8 1771 1772 O
At 9 11 1773 1775 O
least 12 17 1776 1781 O
2 18 19 1782 1783 B-lower_bound
weeks 20 25 1784 1789 I-lower_bound
since 26 31 1790 1795 O
undergoing 32 42 1796 1806 O
any 43 46 1807 1810 O
major 47 52 1811 1816 B-treatment
surgery 53 60 1817 1824 I-treatment

Total 0 5 1825 1830 B-clinical_variable
bilirubin 6 15 1831 1840 I-clinical_variable
≤ 16 17 1841 1842 O
1.5 18 21 1843 1846 B-upper_bound
x 22 23 1847 1848 I-upper_bound
ULN 24 27 1849 1852 I-upper_bound
for 28 31 1853 1856 O
age 32 35 1857 1860 B-age

Tufted 0 6 1861 1867 B-cancer
angioma 7 14 1868 1875 I-cancer

Urine 0 5 1876 1881 B-clinical_variable
protein 6 13 1882 1889 I-clinical_variable
to 14 16 1890 1892 I-clinical_variable
creatinine 17 27 1893 1903 I-clinical_variable
ratio 28 33 1904 1909 I-clinical_variable
( 34 35 1910 1911 I-clinical_variable
UPC 35 38 1911 1914 I-clinical_variable
) 38 39 1914 1915 I-clinical_variable
< 40 41 1916 1917 O
0.3 42 45 1918 1921 B-upper_bound
g 46 47 1922 1923 I-upper_bound
/ 47 48 1923 1924 I-upper_bound
l 48 49 1924 1925 I-upper_bound

